Early luteal function following danazol therapy for endometriosis

Area of Science:

• Reproductive Endocrinology
• Gynecology

Background:

• Endometriosis is associated with infertility and increased fetal wastage.
• Danazol is a common treatment for endometriosis, but its long-term effects on reproductive outcomes require further investigation.

Purpose of the Study:

• To evaluate the luteal phase function after danazol therapy in infertile women with endometriosis.
• To determine if danazol treatment causes endometrial inadequacy or hormonal imbalances affecting pregnancy.

Main Methods:

• Studied 20 infertile women with endometriosis post-danazol treatment.
• Assessed basal body temperature, plasma progesterone, estradiol, and prolactin.
• Analyzed endometrial biopsy samples for secretory phase adequacy.

Main Results:

• All endometrial specimens showed adequate progestational changes.
• Plasma hormone levels (progesterone, estradiol, prolactin) were within normal ranges.
• Abnormal secretory phases occurred in only three patients, consistent with pre-danazol cycles.

Conclusions:

• Endometrial inadequacy is not the cause of increased fetal wastage after danazol therapy for endometriosis.
• Danazol treatment does not appear to impair luteal phase function or hormonal balance.
• Further research is needed to identify the causes of fetal wastage in women with endometriosis treated with danazol.